01/02/2011
In accordance with the Financial Services Authority’s Disclosure and Transparency Rules, the Company hereby announces that it has 89,446,548 ordinary shares of 0.01p each in issue, each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.
The above figure of 89,446,548 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority’s Disclosure and Transparency Rules.
Enquiries:
ReGen Therapeutics Plc
Percy Lomax
+44 20 7153 4920
Cairn Financial Advisers LLP
Nominated Adviser
Liam Murray / Avi Robinson
+44 20 7148 7900
Alexander David Securities Limited
Broker
David Scott / Nick Bealer
+44 20 7448 9820